Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR
![PDF) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake PDF) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake](https://i1.rgstatic.net/publication/275280629_Benzo-fused_lactams_from_a_diversity-oriented_synthesis_DOS_library_as_inhibitors_of_scavenger_receptor_BI_SR-BI-mediated_lipid_uptake/links/554a59540cf21ed21358e375/largepreview.png)
PDF) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake
![Bioorganic & Medicinal Chemistry Letters | Vol 27, Issue 20, Pages 4589-4780 (15 October 2017) | ScienceDirect.com by Elsevier Bioorganic & Medicinal Chemistry Letters | Vol 27, Issue 20, Pages 4589-4780 (15 October 2017) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X17X0019X-cov200h.gif)
Bioorganic & Medicinal Chemistry Letters | Vol 27, Issue 20, Pages 4589-4780 (15 October 2017) | ScienceDirect.com by Elsevier
![Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin | ACS Medicinal Chemistry Letters Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/amclct.2020.11.issue-8/asset/amclct.2020.11.issue-8.largecover.jpg)
Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin | ACS Medicinal Chemistry Letters
![Our paper interrogating the NMR binding detection limits of fragments targeting the VHL-HIF1α PPI is now published in ACS Med. Chem. Lett. | Ciulli Laboratory Our paper interrogating the NMR binding detection limits of fragments targeting the VHL-HIF1α PPI is now published in ACS Med. Chem. Lett. | Ciulli Laboratory](https://www.lifesci.dundee.ac.uk/groups/alessio-ciulli//sites/ciulli.aegir-p1.lifesci.dundee.ac.uk/files/ml-2013-00296c_0002.jpeg)
Our paper interrogating the NMR binding detection limits of fragments targeting the VHL-HIF1α PPI is now published in ACS Med. Chem. Lett. | Ciulli Laboratory
Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546 | ACS Medicinal Chemistry Letters
![PDF) Synthesis of antitrypanosomal 1,2-dioxane derivatives based on a natural product scaffold | Ngoc Pham - Academia.edu PDF) Synthesis of antitrypanosomal 1,2-dioxane derivatives based on a natural product scaffold | Ngoc Pham - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/89790251/mini_magick20220817-1-72ykz4.png?1660706191)
PDF) Synthesis of antitrypanosomal 1,2-dioxane derivatives based on a natural product scaffold | Ngoc Pham - Academia.edu
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commerci
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation | ACS Medicinal Chemistry Letters
![ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based](https://pbs.twimg.com/media/FI--VCbXMAQrvvI.jpg)